iSpecimen gets Nasdaq extension until Nov. 25, 2026 to regain compliance
Nasdaq granted iSpecimen an extension until Nov. 25, 2026 to regain compliance with Listing Rule 5550(b) on minimum stockholders' equity. The company said it plans prior and planned financings to regain compliance.